PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers construct RNA nanoparticles to safely deliver long-lasting therapy to cells

2011-04-24
(Press-News.org) CINCINNATI—Nanotechnology researchers have known for years that RNA, the cousin of DNA, is a promising tool for nanotherapy, in which therapeutic agents can be delivered inside the body via nanoparticles. But the difficulties of producing long-lasting, therapeutic RNA that remains stable and non-toxic while entering targeted cells have posed challenges for their progress.

In two new publications in the journal Molecular Therapy, University of Cincinnati (UC) biomedical engineering professor Peixuan Guo, PhD, details successful methods of producing large RNA nanoparticles and testing their safety in the delivery of therapeutics to targeted cells.

The articles, in advance online publication, represent "two very important milestones in RNA nanotherapy," says Guo. "One problem in RNA therapy is the requirement for the generation of relatively large quantities of RNA," he says. "In this research, we focused on solving the most challenging problem of industry-scale production of large RNA molecules by a bipartite approach, finding that pRNA can be assembled from two pieces of smaller RNA modules."

Guo, Dane and Mary Louise Miller Endowed Chair of biomedical engineering, serves as director of the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer Platform Partnership Program at UC. He has focused his research on RNA for decades, pioneering its use as a versatile building block for nanotechnology, or for the engineering of functional systems at the molecular scale. In 1987, he discovered a packaging RNA (pRNA) in the bacteriophage phi29 virus which can gear a motor to package DNA into the viral protein shell. In 1998, his lab discovered that pRNA can self-assemble or be engineered into nanoparticles to gear the motor.

In his most recent research, Guo and colleagues detail multiple approaches for the construction of a functional 117-base pRNA molecule containing small interfering RNA (siRNA). siRNA has already been shown to be an efficient tool for silencing genes in cells, but previous attempts have produced chemically modified siRNA lasting only 15-45 minutes in the body and often inducing undesired immune responses.

"The pRNA particles we constructed to harbor siRNA have a half life of between five and 10 hours in animal models, are non-toxic and produce no immune response," says Guo. "The tenfold increase of circulation time in the body is important in drug development and paves the way towards clinical trials of RNA nanoparticles as therapeutic drugs."

Guo says the size of the constructed pRNA molecule is crucial for the effective delivery of therapeutics to diseased tissues.

"RNA nanoparticles must be within the range of 15 to 50 nanometers," he says, "large enough to be retained by the body and not enter cells randomly, causing toxicity, but small enough to enter the targeted cells with the aid of cell surface receptions."

In the paper, "Assembly of Therapeutic pRNA-siRNA Nanoparticles Using Bipartite Approach," Guo and his colleagues used two synthetic RNA fragments to create the 117-base pRNA, which was able to further assemble with other pRNA molecules and function in the bacteriophage phi29 viral motor to package DNA.

"The two-piece approach in pRNA synthesis overcame challenges of size limitations in chemical synthesis of RNA nanoparticles," Guo wrote. "The resulting nanoparticles were competent in delivering and releasing therapeutics to cells and silencing the genes within them. The ability to chemically synthesize these nanoparticles allows for further chemical modification of RNA for stability and specific targeting."

The second publication, "Pharmacological Characterization of Chemically Synthesized Monomeric phi29 pRNA Nanoparticles for Systemic Delivery," builds on that research, demonstrating that modified three-dimensional pRNA nanoparticles were readily manufactured through the two-piece approach. The modified nanoparticles were resistant to common enzymes that can attack and degrade RNA and remained chemically and metabolically stable.

Furthermore, when delivered to target cells in an animal model, the nanoparticles were non-toxic and did not induce an immune response, enabling the nanoparticles to bind to cancer cells in vivo.

Previous studies have encased therapeutic siRNA in a polymer coating or liposome for delivery to cells.

"To our knowledge, this is the first naked RNA nanoparticles to have been comprehensively examined pharmacologically in vivo and demonstrated to be safe, as well as deliver itself to tumor tissues by a specific targeting mechanism," says Guo. "It suggests that the pRNA nanoparticles without coating have all the preferred pharmacological features to serve as an efficient nanodelivery platform for broad medical applications."

INFORMATION:

Co-authors of "Assembly of Therapeutic pRNA-siRNA Nanoparticles Using Bipartite Approach" include Yi Shu, Mathieu Cinier, Sejal Fox and Nira Ben-Johnathan of the University of Cincinnati.

Co-authors of "Pharmacological Characterization of Chemically Synthesized Monomeric phi29 pRNA Nanoparticles for Systemic Delivery" include Sherine Abdelmawla and Songchuan Guo of Kylin Therapeutics and Purdue University, Limin Zhang, Sai M Pulukuri, Prithviraj Patankar, Patrick Conley, Joseph Trebley and Qi-Xiang Li of Kylin Therapeutics.

This study was funded by National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institute of General Medical Sciences and Kylin Therapeutics Inc. Guo is co-founder of Kylin Therapuetics.

END



ELSE PRESS RELEASES FROM THIS DATE:

Worm studies shed light on human cancers

2011-04-24
MADISON -- Research in the worm is shedding light on a protein associated with a number of different human cancers, and may point to a highly targeted way to treat them. University of Wisconsin-Madison scientists were studying a worm protein called TFG-1, which is present in many cell types but whose exact role had never been understood. The scientists discovered that the protein controls key aspects of the movement, or secretion, of growth factors out of cells. "TFG-1 has never been implicated in the secretory process before," says Dr. Anjon Audhya, an assistant ...

LateRooms.com - See Classical Guitarist Craig Ogden in Pembrokeshire

2011-04-24
Craig Ogden will bring his virtuoso guitar skills to Pembrokeshire's Torch Theatre this summer. The Australian-born musician is due to perform at the Milford Haven venue on Tuesday June 21st, when his repertoire will include works by Albeniz, Barrios and Fernando Sor. Ogden, whose album The Guitarist was widely acclaimed by classical music critics last year, has been studying the instrument since the age of seven. In 2004, he was honoured with a fellowship in recognition of his achievements from the Royal Northern College of Music, becoming the youngest performer ...

Starting a new metabolic path

Starting a new metabolic path
2011-04-24
Efforts to engineer new metabolic pathways into microbes for the inexpensive production of valuable chemical products, such as biofuels or therapeutic drugs, should get a significant boost in a new development from the U.S. Department of Energy (DOE)'s Joint BioEnergy Institute (JBEI). Researchers there have successfully demonstrated a technique they call "targeted proteomics" that speeds up and improves the ability to identify and quantify specific proteins within a cell or microorganism. "Metabolic engineers and synthetic biologists can use our directed proteomic technique ...

LateRooms.com - Berlin Gets Ready for International Design Festival

2011-04-24
The DMY International Design Festival returns to Berlin with a fresh line-up of exhibitions, workshops and other special events this summer. Running from Wednesday June 1st to Sunday June 5th at the city's Tempelhof Airport site, the annual extravaganza will showcase the latest in contemporary design trends and innovative products. The festival's central exhibition is set to occupy an area of 14,000 sq m in the spacious aircraft hangars of Tempelhof, which ceased operating as a commercial airport in 2008. Now used to host major public events and music festivals, ...

Musical activity may improve cognitive aging

Musical activity may improve cognitive aging
2011-04-24
ATLANTA – A study conducted by Brenda Hanna-Pladdy, PhD, a clinical neuropsychologist in Emory's Department of Neurology, and cognitive psychologist Alicia MacKay, PhD, found that older individuals who spent a significant amount of time throughout life playing a musical instrument perform better on some cognitive tests than individuals who did not play an instrument. The findings were published in the April journal Neuropsychology. While much research has been done to determine the cognitive benefits of musical activity by children, this is the first study to examine ...

Entrepreneurship urged to stimulate the economy

2011-04-24
Los Angeles, CA (APRIL XX, 2011) Economists have been pointing to the growth in entrepreneurship and small business hiring as two ways the US economy can speed the recovery process. In his first ever Facebook town hall meeting, President Obama expanded upon this search for economic solutions as part of the White House's "Startup America" initiative. Recent articles show that researchers not only support these notions, but also break them down for the nation and the world. Current entrepreneurial scholarship offers studies that provide avenues for future research and ...

LateRooms.com - Munich to Welcome Emmylou Harris

2011-04-24
Country music legend Emmylou Harris is due to make a rare appearance in Munich this summer. The 12-time Grammy winner will play at the German city's Philharmonie venue on Sunday June 5th, giving fans a chance to hear songs from her 40-year career in the music industry. Harris is due to release Hard Bargain, her latest studio LP, via Nonesuch Records on April 26th. The album features a new composition called The Road, which recalls the time the songwriter spent playing and recording with her mentor Gram Parsons during the early 1970s. On her official website, ...

Discovery identifies elaborate G-protein network in plants

Discovery identifies elaborate G-protein network in plants
2011-04-24
The most elaborate heterotrimeric G-protein network known to date in the plant kingdom has been identified by Dr. Sona Pandey, principal investigator at the Danforth Plant Science Center. The results of this research are published in the recent article, "An elaborate heterotirmeric G-protein family from soybean expands the diversity of G-protein networks," in the New Phytologist. G-proteins are signaling proteins that direct a plant's response to various environmental signals including abiotic and biotic stresses such as drought and disease resistance. Prior to Dr. ...

USC research shows critical role of placenta in brain development

2011-04-24
Research at the Keck School of Medicine of the University of Southern California's (USC) Zilkha Neurogenetic Institute shows for the first time that the human placenta plays an active role in synthesizing serotonin, paving the way to new treatment strategies that could mitigate health impacts such as cardiovascular disease and mental illness. The groundbreaking findings, conducted with researchers from Vanderbilt University as part of a Silvio Conte Center of Excellence grant from the National Institute of Mental Health, offer conclusive evidence that the placenta provides ...

Drug effective in treating kidney disease in diabetic patients

2011-04-24
Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health (NIH) and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology (JASN). Diabetic nephropathy remains the leading cause of end-stage kidney disease (ESKD) in the United States. It is a common complication of diabetes, ...

LAST 30 PRESS RELEASES:

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting

Early detection model for pancreatic necrosis improves patient outcomes

Poor vascular health accelerates brain ageing

[Press-News.org] Researchers construct RNA nanoparticles to safely deliver long-lasting therapy to cells